We have further examined this initial finding using quantitative PCR (qPCR) analysis, western immunoblotting of the same cell lines, chemosensitivity testing and analysis of freshly extracted ovarian cancer tissue for mRNA levels of p57Kip2 with assessment of clinico-pathological features. The gene discussed is CDKN1C; the disease is ovarian cancer.